<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1343858</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Plasmid-encoded gene duplications of extended-spectrum &#x3b2;-lactamases in clinical bacterial isolates</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sobkowiak</surname>
<given-names>Annika</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2616132"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scherff</surname>
<given-names>Natalie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schuler</surname>
<given-names>Franziska</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bletz</surname>
<given-names>Stefan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mellmann</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/735603"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schwierzeck</surname>
<given-names>Vera</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/835062"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>van Almsick</surname>
<given-names>Vincent</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1634854"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Hygiene, University Hospital M&#xfc;nster</institution>, <addr-line>M&#xfc;nster</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Cardiology I &#x2013; Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital M&#xfc;nster</institution>, <addr-line>M&#xfc;nster</addr-line>, <country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Medical Microbiology, University Hospital M&#xfc;nster</institution>, <addr-line>M&#xfc;nster</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Marion Skalweit, Case Western Reserve University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Anand Bahadur Karki, Sam Houston State University, United States</p>
<p>Ibrahim Bitar, Charles University, Czechia</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Vincent van Almsick, <email xlink:href="mailto:VincentFrederic.vanAlmsick@ukmuenster.de">VincentFrederic.vanAlmsick@ukmuenster.de</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1343858</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Sobkowiak, Scherff, Schuler, Bletz, Mellmann, Schwierzeck and van Almsick</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Sobkowiak, Scherff, Schuler, Bletz, Mellmann, Schwierzeck and van Almsick</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>The emergence of extended-spectrum &#x3b2;-lactamase (ESBL)-producing Enterobacteriaceae is an urgent and alarming One Health problem. This study aimed to investigate duplications of plasmid-encoded ESBL genes and their impact on antimicrobial resistance (AMR) phenotypes in clinical and screening isolates.</p>
</sec>
<sec>
<title>Methods</title>
<p>Multi-drug-resistant bacteria from hospitalized patients were collected during routine clinical surveillance from January 2022 to June 2023, and their antimicrobial susceptibility patterns were determined. Genotypes were extracted from long-read whole-genome sequencing data. Furthermore, plasmids and other mobile genetic elements associated with ESBL genes were characterized, and the ESBL genes were correlated to ceftazidime minimal inhibitory concentration (MIC).</p>
</sec>
<sec>
<title>Results</title>
<p>In total, we identified four cases of plasmid-encoded ESBL gene duplications that match four genetically similar plasmids during the 18-month surveillance period: five <italic>Escherichia coli</italic> and three <italic>Klebsiella pneumoniae</italic> isolates. As the ESBL genes were part of transposable elements, the surrounding sequence regions were duplicated as well. In-depth analysis revealed insertion sequence (IS)-mediated transposition mechanisms. Isolates with duplicated ESBL genes exhibited a higher MIC for ceftazidime in comparison to isolates with a single gene copy (3&#x2013;256 <italic>vs.</italic> 1.5&#x2013;32 mg/L, respectively).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>ESBL gene duplications led to an increased phenotypic resistance against ceftazidime. Our data suggest that ESBL gene duplications by an IS-mediated transposition are a relevant mechanism for how AMR develops in the clinical setting and is part of the microevolution of plasmids.</p>
</sec>
</abstract>
<kwd-group>
<kwd>antimicrobial resistance</kwd>
<kwd>ESBL</kwd>
<kwd>plasmid</kwd>
<kwd>transposons</kwd>
<kwd>gene duplication</kwd>
<kwd>antibiotic susceptibility</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="57"/>
<page-count count="10"/>
<word-count count="4623"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Antibiotic Resistance and New Antimicrobial drugs</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Antimicrobial resistance (AMR) is an alarming and urgent One Health problem (<xref ref-type="bibr" rid="B55">Ventola, 2015</xref>; <xref ref-type="bibr" rid="B32">Kim and Cha, 2021</xref>). AMR allows bacteria to resist and persist even though antibiotics are present. Ever since the first introduction of antimicrobials, the number of resistant bacteria has steadily increased and is becoming a major challenge for healthcare systems worldwide (<xref ref-type="bibr" rid="B14">Davies and Davies, 2010</xref>; <xref ref-type="bibr" rid="B40">O&#x2019;Neill, 2014</xref>; <xref ref-type="bibr" rid="B37">Murray et&#xa0;al., 2022</xref>). The dissemination of AMR is driven by a combination of different factors such as the extensive use of antimicrobial agents (<xref ref-type="bibr" rid="B5">Browne et&#xa0;al., 2021</xref>) as well as selection pressure in almost all environments (<xref ref-type="bibr" rid="B33">Kizny Gordon et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B10">Chen et&#xa0;al., 2019</xref>). Especially in the hospital setting, AMR is a major concern, as they limit treatment options for serious bacterial infections significantly (<xref ref-type="bibr" rid="B27">Huemer et&#xa0;al., 2020</xref>).</p>
<p>Hydrolysis of the &#x3b2;-lactam ring of penicillin, the first discovered antibiotic agent, and their derivates by &#x3b2;-lactamases, is among the most important AMR mechanisms. In 1965, the first plasmid-encoded &#x3b2;-lactamase TEM-1 was discovered, which provided significant resistance in addition to the natural occurrence of chromosomal &#x3b2;-lactamase genes (<xref ref-type="bibr" rid="B13">Datta and Kontomichalou, 1965</xref>). Point mutations in the <italic>bla</italic> genes coding for &#x3b2;-lactamases generate the fast-growing family of extended-spectrum beta-lactamases (ESBLs), i.e., TEM-type and SHV-type &#x3b2;-lactamases (<xref ref-type="bibr" rid="B4">Bradford, 2001</xref>; <xref ref-type="bibr" rid="B2">Behzadi et&#xa0;al., 2020</xref>). ESBLs also provide resistance against newer antibiotic classes such as aminopenicillins and cephalosporins. The most commonly found and clinically relevant ESBL genes are <italic>bla</italic>
<sub>TEM</sub>, <italic>bla</italic>
<sub>SHV</sub>, and <italic>bla</italic>
<sub>CTX-M</sub> (<xref ref-type="bibr" rid="B34">Liakopoulos et&#xa0;al., 2016</xref>).</p>
<p>ESBL-producing Enterobacteriaceae (<xref ref-type="bibr" rid="B4">Bradford, 2001</xref>) are of special concern in the healthcare setting, as they are listed as critical in the priority pathogens list by the WHO (<xref ref-type="bibr" rid="B48">Tacconelli et&#xa0;al., 2018</xref>). Most ESBL-producing Enterobacteriaceae in the hospital setting can be identified as <italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae.</italic> For ESBL-producing <italic>E. coli</italic>, an asymptomatic and persistent carriage in the human intestine is well-known and has been increasing in the last decades (<xref ref-type="bibr" rid="B3">Bezabih et&#xa0;al., 2021</xref>).</p>
<p>Most AMR genes are coded as accessory genes on mobile genetic elements (MGEs) (<xref ref-type="bibr" rid="B41">Partridge et&#xa0;al., 2018</xref>) that can be transferred among bacteria on plasmids via conjugation. This conjugation is possible not only between bacteria of the same species but also beyond species borders within a multispecies bacterial community. Therefore, plasmids are believed to be the key drivers in the development and spread of antimicrobial resistance (<xref ref-type="bibr" rid="B7">Carattoli, 2009</xref>). Furthermore, different types of transposons are described as MGEs used to transfer AMR genes (<xref ref-type="bibr" rid="B20">Frost et&#xa0;al., 2005</xref>). There, AMR genes are often found as accessory genes, for example, within composite transposons. These transposons are characterized by flanking insertion sequence (IS) coding a transposase, and AMR and virulence genes in between. The transposase uses the IS as recognition sites to transfer the whole transposon from one position in the DNA to another as well as from plasmids to the chromosome if a suitable site is found. Other AMR gene transpositions are carried out by unit transposons, where an IS transposase is only found on one site of the AMR gene (<xref ref-type="bibr" rid="B26">He et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B54">Varani et&#xa0;al., 2021</xref>).</p>
<p>For many years, the investigation of AMR plasmids has been labor-intensive due to the shortfalls of short-read whole-genome sequencing (WGS) technology. For instance, short-read WGS only covers parts of transposons, which leads to possible misassemblies of these sequence repetitions (<xref ref-type="bibr" rid="B31">Juraschek et&#xa0;al., 2021</xref>). Recent long-read WGS offers a significant advantage by enabling the complete coverage of plasmids or the generation of reads that span entire transposons. This capability simplifies the detection of transposons and gene duplications within the sequences.</p>
<p>To increase the understanding of AMR development and spread especially in ESBLs, we analyzed multi-drug-resistant Enterobacteriaceae isolated from clinical samples in more detail by long-read WGS. Although plasmids are key drivers of AMR spread, only little is known about the evolutionary and molecular mechanisms of plasmids harboring AMR genes in the clinical setting. Here, we characterize four cases of ESBL gene duplications on plasmids and demonstrate how these duplications affect the AMR phenotype.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Material and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Clinical setting and bacterial isolates</title>
<p>The University Hospital M&#xfc;nster (UHM) is a 1,300-bed tertiary care center in M&#xfc;nster, Germany, admitting on average 55,000 patients per year. Bacterial samples were collected from hospitalized patients at the UHM for an 18-month time period from January 2022 to June 2023 as part of the routine hospital surveillance of multi-drug-resistant bacteria (MDRBs) according to national recommendations (<xref ref-type="bibr" rid="B6">Bundesgesundheitsblatt, 2012</xref>). Screening specimens were cultivated on chromID ESBL Agar (biom&#xe9;rieux, Marcy-l&#x2019;Etoile, France) and incubated at 36&#xb0;C &#xb1; 1&#xb0;C for 18 to 24&#xa0;h. Clinical specimens were cultivated on Columbia Blood agar with 5% Sheep Blood (BD, Heidelberg, Germany; aerobic incubation at 35&#xb0;C &#xb1; 2&#xb0;C ambient air for up to 3 days), and MacConkey selective agar for Gram-negative bacteria (MacConkey II Agar, BD, Heidelberg, Germany; aerobic incubation at ambient air 35&#xb0;C &#xb1; 2&#xb0;C for up to 2 days) if applicable. During the study period, &gt;500 MDRB Enterobacteriaceae isolates were identified.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Species identification</title>
<p>Species identification was performed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) (MALDI-TOF MS, Biotyper<sup>&#xae;</sup> Sirius one, Bruker, Bremen, Germany) with scores above 2.0.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Antimicrobial susceptibility testing</title>
<p>Antimicrobial susceptibility testing was performed using VITEK<sup>&#xae;</sup>2 automated system (biom&#xe9;rieux, Marcy-l&#x2019;Etoile, France). In addition, Etests<sup>&#xae;</sup> (biom&#xe9;rieux, Marcy-l&#x2019;Etoile, France) for ceftazidime were performed on M&#xfc;ller-Hinton-Agar (Oxoid, Schwerte, Germany) to determine the minimal inhibitory concentration (MIC). All MICs were interpreted according to the 2023 European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints version 13.1 (<xref ref-type="bibr" rid="B17">EUCAST, 2023</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Whole-genome sequencing</title>
<p>DNA from bacterial isolates was extracted using the NEB Monarch Purification Kit (New England Biolabs, Ipswich, MA, USA) and sequenced on a PacBio<sup>&#xae;</sup> Sequel IIe system (Pacific Biosciences, Menlo Park, CA, USA) as described previously (<xref ref-type="bibr" rid="B16">Effelsberg et&#xa0;al., 2021</xref>). A <italic>de novo</italic> assembly approach was used for the raw reads and analyzed using the SMRT<sup>&#xae;</sup> Link software suite v. 10 or v. 11 with default parameters.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Whole-genome data analysis, annotation, and visualization</title>
<p>The phylogenetic tree was generated based on WGS data by the Genome BLAST Distance Phylogeny (GBDP) approach using the Type Strain Genome Server (<xref ref-type="bibr" rid="B36">Meier-Kolthoff and G&#xf6;ker, 2019</xref>). For genotyping based on multilocus sequence typing (MLST) and core genome MLST (cgMLST) and to determine the clonal relationship, the respective schemes in Ridom SeqSphere<sup>+</sup> software version 9.0.9 (Ridom GmbH, M&#xfc;nster, Germany) were used (<xref ref-type="bibr" rid="B30">J&#xfc;nemann et&#xa0;al., 2013</xref>). Isolates were rated as clonal when the distance of their cgMLST allelic profiles was &#x2264;5 alleles. Antimicrobial resistance genes were determined using the NCBI AMRFinderPlus (<xref ref-type="bibr" rid="B18">Feldgarden et&#xa0;al., 2019</xref>) implemented in SeqSphere<sup>+</sup>. If duplicated AMR ESBL genes were identified, a more detailed analysis of the respective contigs was performed. Contigs were predicted as plasmids using MOB-Suite v3.1.4 (<xref ref-type="bibr" rid="B42">Robertson and Nash, 2018</xref>) and further characterized by pMLST Server 2.0 (<xref ref-type="bibr" rid="B9">Carattoli et&#xa0;al., 2014</xref>). Plasmids were completely annotated using DFAST v1.6.0 (including additional scans against TIGRFAM and COG database by NCBI) (<xref ref-type="bibr" rid="B50">Tanizawa et&#xa0;al., 2018</xref>). Next, it was searched for genetically matching plasmids with the same ESBL gene but without a gene duplication in the dataset by a mash-based approach (<xref ref-type="bibr" rid="B39">Ondov et&#xa0;al., 2016</xref>) implemented in SeqSphere<sup>+</sup>. Isolates containing these plasmids were used as references and were analyzed in the same way.</p>
<p>Progressive Mauve (<xref ref-type="bibr" rid="B12">Darling et&#xa0;al., 2004</xref>) was used to compare and visualize the similarity of plasmid sequences and to localize the gene duplication site of the transposable regions. In addition, all mobile genetic elements were annotated using ISFinder (<xref ref-type="bibr" rid="B47">Siguier et&#xa0;al., 2006</xref>) and MobileElementFinder with the default parameters (<xref ref-type="bibr" rid="B29">Johansson et&#xa0;al., 2021</xref>). Plasmid sequences were manually curated using SnapGene<sup>&#xae;</sup> Viewer (Dotmatics; <ext-link ext-link-type="uri" xlink:href="http://www.snapgene.com">www.snapgene.com</ext-link>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Characteristics of bacterial isolates</title>
<p>We identified four isolates (three <italic>E. coli</italic> and one <italic>K. pneumoniae</italic>) containing more than one plasmid-based ESBL gene copy within the isolates found by our routine molecular surveillance. For comparison, we matched these four isolates with more than one plasmid-based ESBL gene to four additional isolates (two <italic>E. coli</italic> and two <italic>K. pneumoniae</italic>) in the dataset containing genetically the same plasmids with only a single ESBL gene copy (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1&#x2013;4</bold>
</xref>). These isolate matches are named pairs I&#x2013;IV and originate from different or the same patient. Details of the isolates analyzed and the patients&#x2019; characteristics are listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. In total, bacterial isolates of six patients were included in the study: four female patients and two male patients. The median age of patients was 63 (32&#x2013;94) years. According to their medical history based on the medical reports, all patients suffered from chronic or severe infections (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Overview of samples analyzed including origin and patients&#x2019; backgrounds.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Plasmid pair</th>
<th valign="middle" align="center">Isolate (patient #)</th>
<th valign="middle" align="center">Specimen</th>
<th valign="middle" align="center">Medical history</th>
<th valign="middle" align="center">Antibiotics prescribed</th>
<th valign="middle" align="center">ST</th>
<th valign="middle" align="center">No. of plasmids detected</th>
<th valign="middle" align="center">ESBL-encoding gene</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="2" align="center">I</td>
<td valign="middle" align="center">Ec1.1 (1)</td>
<td valign="middle" align="center">Rectal screening</td>
<td valign="middle" align="center">Colorectal cancer with liver metastasis</td>
<td valign="middle" align="center">Piperacillin&#x2013;tazobactam, vancomycin, micafungin</td>
<td valign="middle" align="center">46</td>
<td valign="middle" align="center">3</td>
<td valign="middle" rowspan="2" align="center">
<italic>bla</italic>
<sub>CTX-M-15</sub>
</td>
</tr>
<tr>
<td valign="middle" align="center">Ec1.2* (2)</td>
<td valign="middle" align="center">Urine</td>
<td valign="middle" align="center">Ulcer (stage IV) requiring reconstructive surgery</td>
<td valign="middle" align="center">Ampicillin&#x2013;sulbactam</td>
<td valign="middle" align="center">69</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="center">II</td>
<td valign="middle" align="center">Ec2.1 (3)</td>
<td valign="middle" rowspan="2" align="center">Tissue</td>
<td valign="middle" rowspan="2" align="center">Recurrent periprosthetic hip joint infection</td>
<td valign="middle" rowspan="2" align="center">Ceftazidime, vancomycin, meropenem</td>
<td valign="middle" align="center">95</td>
<td valign="middle" align="center">4</td>
<td valign="middle" rowspan="2" align="center">
<italic>bla</italic>
<sub>SHV-12</sub>
</td>
</tr>
<tr>
<td valign="middle" align="center">Kp2.2* (3)</td>
<td valign="middle" align="center">353</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="center">III</td>
<td valign="middle" align="center">Ec3.1 (4)</td>
<td valign="middle" align="center">Drainage fluid</td>
<td valign="middle" align="center">Primary sclerosing cholangitis, Klatskin tumor, recurrent episodes of cholangitis</td>
<td valign="middle" align="center">Ceftriaxone</td>
<td valign="middle" align="center">453</td>
<td valign="middle" align="center">3</td>
<td valign="middle" rowspan="2" align="center">
<italic>bla</italic>
<sub>CTX-M-14</sub>
</td>
</tr>
<tr>
<td valign="middle" align="center">Ec3.2* (5)</td>
<td valign="middle" align="center">Urine</td>
<td valign="middle" align="center">Cystectomy, recurrent urinary tract infections</td>
<td valign="middle" align="center">Nitrofurantoin and others (unspecified, outpatient prescription)</td>
<td valign="middle" align="center">453</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="center">IV</td>
<td valign="middle" align="center">Kp4.1 (6)</td>
<td valign="middle" align="center">Blood culture</td>
<td valign="middle" rowspan="2" align="center">Renal transplant, recurrent episodes of pyelonephritis</td>
<td valign="middle" rowspan="2" align="center">Cotrimoxazole, amphotericin B</td>
<td valign="middle" align="center">1,634</td>
<td valign="middle" align="center">1</td>
<td valign="middle" rowspan="2" align="center">
<italic>bla</italic>
<sub>SHV-2</sub>
</td>
</tr>
<tr>
<td valign="middle" align="center">Kp4.2* (6)</td>
<td valign="middle" align="center">Urine</td>
<td valign="middle" align="center">1,634</td>
<td valign="middle" align="center">2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Isolates containing ESBL gene duplications are marked with an asterisk.</p>
</fn>
<fn>
<p>Ec, Escherichia coli; Kp, Klebsiella pneumoniae; ST, sequence type; ESBL, extended-spectrum &#x3b2;-lactamase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The phylogenetic relation of all isolates was calculated based on the WGS data to illustrate the phylogenetic similarity between the isolates in pairs III and IV and the species difference in pair II (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). In case the matched isolates were the same species, cgMLST typing was performed to determine whether the pairs only share a similar plasmid or in addition have a clonal relation (on the chromosomal level). The isolates of pairs I and III did not show clonality in cgMLST analysis among the <italic>E. coli</italic> isolates (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Pair IV was identified as a clonal lineage of <italic>K. pneumoniae</italic> isolates found in one patient (patient 6). Here, the isolates were collected 3 weeks apart in different sample materials (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). The similar plasmids of pair II were shared between an <italic>E. coli</italic> isolate and a <italic>K. pneumoniae</italic> isolate that originated from the same specimen of patient 3 (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>). There was no clonal relationship due to the two different bacterial species.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Relationship of the four pairs of isolates included. <bold>(A)</bold> Phylogenetic tree based on whole-genome sequences of the eight isolates calculated by Type (Strain) Genome Server. The branch lengths are scaled in terms of Genome BLAST Distance Phylogeny distance formula. The pairs describe the compared plasmids of the isolates. Below the isolate name, the sequence type (ST) of each isolate is given. <bold>(B)</bold> Detailed relation within the pairs of isolates of the same species using cgMLST. Each circle is a separate genotype based on the allelic profile of up to 2,325 genes for <italic>Escherichia coli</italic> and 2,358 genes for <italic>Klebsiella pneumoniae</italic>, with the parameter &#x201c;ignoring missing genes in the pairwise comparison&#x201d;. The number on the connecting lines displays the allelic distance.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1343858-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>In-depth analysis of plasmids harboring ESBL-encoding genes</title>
<p>Using the MOB-suite software and AMRFinderPlus tool, we analyzed the plasmids harboring ESBL genes with respect to their sizes, replication and relaxase types, anticipated/predicted mobility, and encoded AMR genes (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Overall, the replication type, the relaxase type, and the predicted mobility of the plasmids were identical within a pair. However, due to the ESBL gene duplication, the plasmid size varied. In addition to the duplicated ESBL-encoding genes, we only found an analog AMR duplication of <italic>qnrS1</italic> in p1_Ec1.2 mediating quinolone resistance. Of note, the similar plasmids p2_Ec2.1 and p2_Kp2.2 are most likely directly related and caused by an intra-host transmission via horizontal gene transfer (HGT) from one species to another.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Characteristics of analyzed plasmid harboring the ESBL genes.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Plasmid</th>
<th valign="top" align="left">Size [bp]</th>
<th valign="top" align="left">Mash distance (hashes)</th>
<th valign="top" align="left">pMLST</th>
<th valign="top" align="left">Replication type/s</th>
<th valign="top" align="left">Relaxase type</th>
<th valign="top" align="left">Predicted mobility</th>
<th valign="top" align="left">AMR genes</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">p3_Ec1.1</td>
<td valign="top" align="left">72,476</td>
<td valign="top" align="left">0.0001<break/>(995/1,000)</td>
<td valign="top" align="left">
<italic>[F2:A-:B-]</italic>
</td>
<td valign="top" align="left">IncFIA, IncFIC</td>
<td valign="top" align="left">MOB<sub>F</sub>
</td>
<td valign="top" align="left">Conjugative</td>
<td valign="top" align="left">
<bold>
<italic>bla</italic>
<sub>CTX-M-15</sub>
</bold>, <italic>qnrS1</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">p1_Ec1.2</td>
<td valign="top" align="left">82,307</td>
<td valign="top" align="left">0.0001<break/>(995/1,000)</td>
<td valign="top" align="left">
<italic>[F2:A-:B-]</italic>
</td>
<td valign="top" align="left">IncFIA, IncFIC</td>
<td valign="top" align="left">MOB<sub>F</sub>
</td>
<td valign="top" align="left">Conjugative</td>
<td valign="top" align="left">
<bold>
<italic>bla</italic>
<sub>CTX-M-15</sub>
</bold>, <bold>
<italic>bla</italic>
<sub>CTX-M-15</sub>
</bold>, <italic>qnrS1</italic>, <italic>qnrS1</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">p2_Ec2.1</td>
<td valign="top" align="left">57,462</td>
<td valign="top" align="left">0.0015<break/>(940/1,000)</td>
<td valign="top" align="left">unknown</td>
<td valign="top" align="left">IncX1, IncX3</td>
<td valign="top" align="left">MOB<sub>P</sub>
</td>
<td valign="top" align="left">Conjugative</td>
<td valign="top" align="left">
<bold>
<italic>bla</italic>
<sub>SHV-12</sub>
</bold>, <italic>bla</italic>
<sub>SHV</sub>-family, <italic>qnrS1</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">p2_Kp2.2</td>
<td valign="top" align="left">66,525</td>
<td valign="top" align="left">0.0015<break/>(940/1,000)</td>
<td valign="top" align="left">unknown</td>
<td valign="top" align="left">IncX1, IncX3</td>
<td valign="top" align="left">MOB<sub>P</sub>
</td>
<td valign="top" align="left">Conjugative</td>
<td valign="top" align="left">
<bold>
<italic>bla</italic>
<sub>SHV-12</sub>
</bold>, <bold>
<italic>bla</italic>
<sub>SHV-12</sub>
</bold>, <italic>bla</italic>
<sub>SHV</sub>-family, <italic>qnrB19</italic>, <italic>qnrS1</italic>,</td>
</tr>
<tr>
<td valign="top" align="left">p2_Ec3.1</td>
<td valign="top" align="left">96,364</td>
<td valign="top" align="left">0.0004<break/>(985/1,000)</td>
<td valign="top" align="left">unknown</td>
<td valign="top" align="left">IncI-gamma/K1</td>
<td valign="top" align="left">MOB<sub>P</sub>
</td>
<td valign="top" align="left">Conjugative</td>
<td valign="top" align="left">
<bold>
<italic>bla</italic>
<sub>CTX-M-14</sub>
</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">p2_Ec3.2</td>
<td valign="top" align="left">100,710</td>
<td valign="top" align="left">0.0004<break/>(985/1,000)</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="left">IncI-gamma/K1</td>
<td valign="top" align="left">MOB<sub>P</sub>
</td>
<td valign="top" align="left">Conjugative</td>
<td valign="top" align="left">
<bold>
<italic>bla</italic>
<sub>CTX-M-14,</sub> <italic>bla</italic>
<sub>CTX-M-14</sub>
</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">p1_Kp4.1</td>
<td valign="top" align="left">53,023</td>
<td valign="top" align="left">0.0001<break/>(997/1,000)</td>
<td valign="top" align="left">
<italic>[F-:A13:B-]</italic>
</td>
<td valign="top" align="left">IncFIA, IncR</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">Mobilizable</td>
<td valign="top" align="left">
<italic>arr-3</italic>, <italic>aac(3)-IId</italic>, <italic>aac(6&#x2032;)-Ib-cr5</italic>, <italic>aadA16</italic>, <italic>tet(D)</italic>, <bold>
<italic>bla</italic>
<sub>SHV-2</sub>
</bold>, <italic>dfrA27</italic>, <italic>sul1</italic>, <italic>sul1</italic>, <italic>qnrB6</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">p1_Kp4.2</td>
<td valign="top" align="left">57,775</td>
<td valign="top" align="left">0.0001<break/>(997/1,000)</td>
<td valign="top" align="left">
<italic>[F-:A13:B-]</italic>
</td>
<td valign="top" align="left">IncFIA, IncR</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">Mobilizable</td>
<td valign="top" align="left">
<italic>arr-3</italic>, <italic>aac(3)-IId</italic>, <italic>aac(6&#x2032;)-Ib-cr5</italic>, <italic>aadA16</italic>, <italic>tet(D)</italic>, <bold>
<italic>bla</italic>
<sub>SHV-2</sub>
</bold>, <bold>
<italic>bla</italic>
<sub>SHV-2</sub>
</bold>, <italic>dfrA27</italic>, <italic>sul1</italic>, <italic>sul1</italic>, <italic>qnrB6</italic>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ESBL genes are indicated by bold letters.</p>
</fn>
<fn>
<p>ESBL, extended-spectrum &#x3b2;-lactamase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>For an in-depth analysis of the plasmids, we annotated the whole plasmids with DFAST and used ISFinder and MobileElementFinder (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1&#x2013;4</bold>
</xref>). All duplicated ESBL genes were part of a longer transposable DNA sequence, which was duplicated in full length (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Transposons harboring the ESBL genes and the duplicated regions. All repeated regions harbor the same genes unless indicated otherwise. The <italic>bla</italic>
<sub>SHV</sub>-family gene is a mutated variant of <italic>bla</italic>
<sub>SHV-12</sub>. Ec, <italic>Escherichia coli</italic>; Kp, <italic>Klebsiella pneumoniae</italic>; ESBL, extended-spectrum &#x3b2;-lactamase; AMR, antimicrobial resistance; IS, insertion sequence; IR, inverted repeats; ESBL, extended-spectrum &#x3b2;-lactamase.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1343858-g002.tif"/>
</fig>
<p>In pair I, the duplication occurred in p1_Ec1.2 as a tandem duplication with flanking IS<italic>26</italic> elements (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>), notably with three IS<italic>26</italic> elements in comparison to p3_Ec1.1 instead of two flanking IS<italic>26</italic> elements for each duplication. The transposon was classified as a composite transposon and harbors the ESBL gene <italic>bla</italic>
<sub>CTX-M-15</sub> as well as the quinolone resistance gene <italic>qnrS1</italic>. In addition to AMR genes, a WbuC family cupin fold metalloprotein and Tn3 transposase were encoded.</p>
<p>In p2_Ec2.1, the reference plasmid of pair II, we already detected an IS<italic>26</italic> tandem duplication of a transposon harboring the ESBL gene <italic>bla</italic>
<sub>SHV-12</sub>. However, there was a difference in the sequence length of one of the transposons caused by an incomplete IS<italic>26</italic> element in the second repeat (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) and a deletion in the ESBL gene (<italic>bla</italic>
<sub>SHV-12</sub>/<italic>bla</italic>
<sub>SHV</sub>-family). A BLAST analysis revealed a deletion of three nucleotides in the ESBL gene coding originally for leucine 53 in <italic>bla</italic>
<sub>SHV-12</sub>. In addition, the transposon contains genes for a PAS domain-containing methyl-accepting chemotaxis protein and for the DNA-binding transcriptional repressor YgbI. While the reference plasmid already shows a duplication, we found a tandem triplication of the transposon in p2_Kp2.2. The coded genes remain the same as in the reference p2_Ec2.1. Nevertheless, one of the three <italic>bla</italic>
<sub>SHV</sub> genes shows a nucleotide deletion as well. The deletion corresponding to threonine 18 in <italic>bla</italic>
<sub>SHV-12</sub> results in a frame shift and an early stop codon, thereby shortening the potentially encoded &#x3b2;-lactamase.</p>
<p>In pair III, we observed another duplication pattern. The ESBL target gene <italic>bla</italic>
<sub>CTX-M-14</sub> in p2_Ec3.2 and the reference plasmid p2_Ec3.1 was carried in an IS<italic>Ecp1</italic>-mediated unit transposon. IS<italic>Ecp1</italic> could be aligned with 100% and 99.94% sequence identities. In addition to the &#x3b2;-lactamase gene, only potential gene residues were transferred within the transposon. The comparison revealed that the point of insertion of the second repeat of the unit transposon in p2_Ec3.2 is the <italic>traU</italic> gene (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<p>The plasmid p1_Kp4.2 belongs to pair IV. A tandem duplication of IS<italic>26</italic>-mediated composite transposons could be detected. The one nucleotide difference in the first repeat in p1_Kp4.2 was caused by an insertion in the already truncated oligosaccharide MFS transporter gene as indicated in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>. The transposon contains the ESBL target gene <italic>bla</italic>
<sub>SHV-2</sub> and a gene for an AAA family ATPase.</p>
<p>Taken together, IS<italic>26</italic>-mediated duplications were found to be tandem duplications, where one IS<italic>26</italic> element is shared between two transposons. This mechanism was identified in three out of four described cases. An alternative mechanism was observed in pair II. Here, a unit transposon was duplicated in an IS<italic>Ecp1</italic>-mediated mode.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Correlation of phenotypic cephalosporin resistance and ESBL gene copies</title>
<p>To investigate the correlation between the phenotypic antimicrobial susceptibility and the presence of AMR resistance genes, we manually curated the VITEK<sup>&#xae;</sup>2 data and used the NCBI AMRFinderPlus to identify matching resistance genes. Furthermore, we used Etests for ceftazidime as a reference substance to determine the cephalosporin resistance more specifically and compare it with the number of ESBL gene copies in the AMR plasmids. In total, AMRFinderPlus annotated 37 different AMR genes within the eight WGS datasets with four to 13 different genes per isolate; including duplications, six to 25 AMR-encoding genes were detected. The lowest numbers of resistance genes were found in Ec1.2 with the duplication of the ESBL gene <italic>bla</italic>
<sub>CTX-M-15</sub> and the <italic>qnrS1</italic>, and <italic>cya</italic>_S352T and <italic>glpT</italic>_E448K. The broadest resistance spectrum showed the three <italic>K. pneumoniae</italic> isolates, with the highest number of AMR genes in Kp4.2. A complete overview of the resistome of the eight analyzed bacterial isolates, categorized into chromosome and plasmid-encoded genes, can be found in the Supplement (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>).</p>
<p>The phenotypic resistance pattern of the bacterial isolates was analyzed by comparing up to 12 different antibiotic substances (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>). All isolates were susceptible to carbapenems, and no carbapenemases were detected in the genomic data. In contrast, all isolates were resistant to ampicillin in line with the expression of at least one &#x3b2;-lactamase also found in the genotypic annotation (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>). To determine the MIC of ceftazidime, we performed Etests<sup>&#xae;</sup>. The MICs within each pair were found to be more than two times higher for the isolates with the ESBL gene duplications compared to the references (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). The elevated resistance to ceftazidime correlates in all pairs with the higher number of the ESBL target genes.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Number of ESBL gene copies in the analyzed plasmids in relation to ceftazidime MIC. ESBL gene copy numbers are color-coded (gray, single copy; black, two copies), and the numbers display the MICs for ceftazidime [mg/L]. ESBL, extended-spectrum &#x3b2;-lactamase; MIC, minimal inhibitory concentration.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1343858-g003.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>The emergence of ESBL-producing Enterobacteriaceae is reported worldwide and poses a substantial threat to public health (<xref ref-type="bibr" rid="B37">Murray et&#xa0;al., 2022</xref>). There is consensus that plasmids are key drivers for the dissemination of AMR genes such as ESBL genes (<xref ref-type="bibr" rid="B8">Carattoli, 2013</xref>). However, little is known about the underlying mechanisms that increase MICs of isolates harboring AMR-encoding genes in the clinical context. Therefore, the aim of our study was to investigate long-read WGS data of clinical bacterial samples with a focus on AMR plasmids and gain insights into the spread of AMR genes in the hospital setting.</p>
<p>We found that ESBL gene duplications occur by transposition events within plasmids and increase the phenotypic resistance against cephalosporins due to the higher gene copy number. Four different cases of gene duplications in plasmids harboring ESBL genes were identified after analyzing the surveillance dataset. Interestingly, all described cases share the IS-mediated transposition with ESBL gene duplication as an <italic>in vivo</italic> evolution event of AMR plasmids and indicate a genotype&#x2013;phenotype correlation between ESBL gene copy number and increased ceftazidime MIC. Our study highlights the potential of long-read WGS data to better understand AMR and the underlying genetic adaptation mechanisms.</p>
<sec id="s4_1">
<label>4.1</label>
<title>Role of plasmids in AMR spread</title>
<p>All presented cases show gene duplications within the plasmid. The association between plasmids, AMR genes, and a high number of plasmid-borne AMR genes is well known (<xref ref-type="bibr" rid="B57">Vrancianu et&#xa0;al., 2020</xref>). Despite the metabolic burden required to maintain a plasmid, most studies could demonstrate that the benefit of the encoded resistance genes is much higher for bacteria or is compensated by additional mutations (<xref ref-type="bibr" rid="B35">Loftie-Eaton et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B44">San Millan and MacLean, 2017</xref>). This seems plausible for the described cases, as all samples were collected from patients who frequently receive antibiotic treatment. Hence, all isolates have experienced selection pressure.</p>
<p>Interestingly, our study observed highly similar plasmids in different bacterial isolates that showed no genetic relation based on cgMLST (pairs I and III). This could be an example illustrating how plasmids are shared within a community of bacteria with different genetic backgrounds. This HGT is an important mechanism to exchange genetic information known for decades (<xref ref-type="bibr" rid="B52">Thomas and Nielsen, 2005</xref>) and well-studied in the adaptive evolution of bacteria (<xref ref-type="bibr" rid="B1">Arnold et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B15">Dimitriu, 2022</xref>). For the <italic>E. coli</italic> Ec2.1 and the <italic>K. pneumoniae</italic> Kp2.2 (pair II), we assume the HGT of the plasmid harboring the ESBL gene because the species borders have to be crossed. However, it is not possible to determine clearly the chronological sequence of the HGT and the duplication event. On note, even if we discuss predominantly the duplication event, the relation between the compared isolates could also be a loss of a transposable region except in pair IV, where the timeline is clear. Kp4.2 was isolated 3 weeks after Kp4.1 from the same patient.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>IS-mediated transposition and other mobile genetic elements associated with ESBL genes</title>
<p>IS-mediated transposition is often observed with accessory genes including AMR genes. All duplication events investigated used this mode of action but with either an IS<italic>26</italic> or an IS<italic>Ecp1</italic> transposition. IS<italic>26</italic> transposition events that could arrange transposons containing AMR genes with only three remaining IS<italic>26</italic> elements were described before including the mechanistic details (<xref ref-type="bibr" rid="B26">He et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B24">Harmer and Hall, 2019</xref>; <xref ref-type="bibr" rid="B25">Harmer and Hall, 2021</xref>). Our data indicate that tandem duplication of the same transposon is also a quite common transposition event as observed in three out of four cases, i.e., in pairs I, III, and IV. In accordance with this observation, a few cases of IS<italic>26</italic>-mediated ESBL gene duplications were described before (<xref ref-type="bibr" rid="B21">Garza-Ramos et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B49">Tamamura-Andoh et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B53">van Almsick et&#xa0;al., 2022</xref>), and also the association of IS<italic>26</italic> and <italic>bla</italic>
<sub>CTX-M</sub> genes was already described in Enterobacteriaceae in a systematic study (<xref ref-type="bibr" rid="B46">Shropshire et&#xa0;al., 2022</xref>). Interestingly, neither documented IS<italic>26</italic> transposon with ESBL genes nor a high sequence similarity could be found in the databases of TnCentral (<xref ref-type="bibr" rid="B43">Ross et&#xa0;al., 2021</xref>) or Transposon Registry (<xref ref-type="bibr" rid="B51">Tansirichaiya et&#xa0;al., 2019</xref>) yet. In the fourth analyzed case (pair II), the transposition was IS<italic>Ecp1</italic> mediated. The detected unit transposon contains a <italic>bla</italic>
<sub>CTX-M-14</sub> gene, which also was found in the <italic>E. coli</italic> isolates of Shropshire et&#xa0;al (<xref ref-type="bibr" rid="B46">Shropshire et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Gene duplications in evolution and correlation to the phenotypic susceptibility</title>
<p>Gene duplication is a common mechanism in evolutionary biology to develop new traits and adaptations (<xref ref-type="bibr" rid="B28">Innan and Kondrashov, 2010</xref>; <xref ref-type="bibr" rid="B56">Vosseberg et&#xa0;al., 2021</xref>). A new variant to improve resistance by mutation might be observed in pair II annotated as <italic>bla</italic>
<sub>SHV</sub> genes in p2_Ec2.1 and p2_Kp2.2 (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). Both investigated plasmids in this pair have different deletions of nucleotides within one gene copy of the ancestor <italic>bla</italic>
<sub>SHV-12</sub> gene. However, it is unclear whether these mutated genes code for a functional and optimized &#x3b2;-lactamase. Schuster et&#xa0;al. found similar results; they identified a novel <italic>bla</italic>
<sub>CTX-M</sub> gene in this context (<xref ref-type="bibr" rid="B45">Schuster et&#xa0;al., 2022</xref>). In that study, the encoded &#x3b2;-lactamase only differed by one amino acid from the ancestor gene that was found in a similar gene array as the new gene. In accordance with this, the evolution of <italic>bla</italic>
<sub>SHV</sub> genes from <italic>bla</italic>
<sub>TEM</sub> with the high sequence similarities underlines this as a plausible mechanism for the generation of novel and better-adapted &#x3b2;-lactamases (<xref ref-type="bibr" rid="B34">Liakopoulos et&#xa0;al., 2016</xref>).</p>
<p>In addition, we hypothesize that the increased resistance level to ceftazidime correlates with the number of ESBL gene copies encoded on the plasmid. Only very few reported cases of ESBL gene duplications found this correlation between genotypic and phenotypic resistance so far (<xref ref-type="bibr" rid="B49">Tamamura-Andoh et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B53">van Almsick et&#xa0;al., 2022</xref>). However, in accordance, this observation has been described before for other AMR genes (<xref ref-type="bibr" rid="B11">Coppi et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B23">Han et&#xa0;al., 2021</xref>). Nevertheless, increased antibiotic resistance has also been linked to point mutations in resistance genes (<xref ref-type="bibr" rid="B19">Finci et&#xa0;al., 2022</xref>). To gain more insights into the genetic resistance patterns of Enterobacteriaceae, more genetic analyses based on studies with higher sample sizes are required.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Study limitations</title>
<p>One limitation of our study is the relatively small number of isolates included in the study. During the 18-month period, four cases of ESBL gene duplications were identified. While this result indicates that ESBL gene duplication is a possible mechanism for developing AMR in the clinical context, higher sample sizes are needed to estimate how frequently this phenomenon happens. Moreover, the comparison of different species and different clonal lineages with variable resistomes has an influence on MIC determination (<xref ref-type="bibr" rid="B22">Girlich et&#xa0;al., 2021</xref>). To consider these aspects, we listed additional &#x3b2;-lactamases encoded on other plasmids or integrated into the chromosome for all isolates (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). Furthermore, the plasmid copy numbers and other regulatory mechanisms were not covered and are out of the scope of this study (<xref ref-type="bibr" rid="B38">Nelson et&#xa0;al., 2017</xref>).</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>We identified IS-mediated AMR gene duplications as a mechanism to overcome antibiotic selection pressure in the hospital setting and to generate new genetic variants of the ancestor resistance gene. Our results also highlight the genetic potential of Enterobacteriaceae for adaptation and evolution of AMR.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</uri>, PRJNA1030289.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>AS: Investigation, Data curation, Formal analysis, Software, Visualization, Writing &#x2013; original draft. NS: Software, Methodology, Validation, Writing &#x2013; review &amp; editing. FS: Methodology, Validation, Writing &#x2013; review &amp; editing, Formal analysis, Resources. SB: Validation, Writing &#x2013; review &amp; editing, Conceptualization. AM: Conceptualization, Data curation, Project administration, Resources, Software, Supervision, Validation, Writing &#x2013; review &amp; editing. VS: Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Supervision, Validation, Writing &#x2013; review &amp; editing. VA: Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AS and VA are supported by a grant (SEED 019/23) from the Interdisciplinary Center of Clinical Research (IZKF), University of M&#xfc;nster.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank the sequencing team of the Institute of Hygiene at the University Hospital M&#xfc;nster and the laboratory team of the Institute of Microbiology at University Hospital M&#xfc;nster for excellent technical assistance.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>NS is a part-time employee of Ridom GmbH.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2024.1343858/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2024.1343858/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>I.-T.</given-names>
</name>
<name>
<surname>Hanage</surname> <given-names>W. P.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Horizontal gene transfer and adaptive evolution in bacteria</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>20</volume>, <fpage>206</fpage>&#x2013;<lpage>218</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-021-00650-4</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behzadi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Perdomo</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Karpi&#x144;ski</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Issakhanian</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Metallo-&#xdf;-lactamases: a review</article-title>. <source>Mol. Biol. Rep.</source> <volume>47</volume>, <fpage>6281</fpage>&#x2013;<lpage>6294</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11033-020-05651-9</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bezabih</surname> <given-names>Y. M.</given-names>
</name>
<name>
<surname>Sabiiti</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Alamneh</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Bezabih</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Bezabhe</surname> <given-names>W. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The global prevalence and trend of human intestinal carriage of ESBL-producing <italic>Escherichia coli</italic> in the community</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>76</volume>, <fpage>22</fpage>&#x2013;<lpage>29</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkaa399</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradford</surname> <given-names>P. A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>14</volume>, <fpage>933</fpage>&#x2013;<lpage>951</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.14.4.933-951.2001</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Browne</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Chipeta</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Haines-Woodhouse</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kumaran</surname> <given-names>E. P. A.</given-names>
</name>
<name>
<surname>Hamadani</surname> <given-names>B. H. K.</given-names>
</name>
<name>
<surname>Zaraa</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Global antibiotic consumption and usage in humans 2000-18: a spatial modelling study</article-title>. <source>Lancet Planet Health</source> <volume>5</volume>, <fpage>e893</fpage>&#x2013;<lpage>e904</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2542-5196(21)00280-1</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>Bundesgesundheitsblatt</collab>
</person-group> (<year>2012</year>). <article-title>Hygienema&#xdf;nahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen St&#xe4;bchen. Empfehlung der Kommission f&#xfc;r Krankenhaushygiene und Infektionspr&#xe4;vention (KRINKO) beim Robert Koch-Institut (RKI)</article-title>. <source>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz</source> <volume>55</volume>, <fpage>1311</fpage>&#x2013;<lpage>1354</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00103-012-1549-5</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carattoli</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Resistance plasmid families in Enterobacteriaceae</article-title>. <source>Antimicrobial. Agents Chemother.</source> <volume>53</volume>, <fpage>2227</fpage>&#x2013;<lpage>2238</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01707-08</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carattoli</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Plasmids and the spread of resistance</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>303</volume>, <fpage>298</fpage>&#x2013;<lpage>304</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijmm.2013.02.001</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carattoli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zankari</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Garc&#xed;a-Fern&#xe1;ndez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Voldby Larsen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lund</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Villa</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>
<italic>In silico</italic> detection and typing of plasmids using plasmidFinder and plasmid multilocus sequence typing</article-title>. <source>Antimicrobial. Agents Chemother.</source> <volume>58</volume>, <fpage>3895</fpage>&#x2013;<lpage>3903</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aac.02412-14</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>E. W.-C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Transmission of ciprofloxacin resistance in Salmonella mediated by a novel type of conjugative helper plasmids</article-title>. <source>Emerg. Microbes Infect.</source> <volume>8</volume>, <fpage>857</fpage>&#x2013;<lpage>865</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/22221751.2019.1626197</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coppi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Di Pilato</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Monaco</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Giani</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Conaldi</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Rossolini</surname> <given-names>G. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae</article-title>. <source>Antimicrobial. Agents Chemother.</source> <volume>64</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01816-19</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darling</surname> <given-names>A. C. E.</given-names>
</name>
<name>
<surname>Mau</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Blattner</surname> <given-names>F. R.</given-names>
</name>
<name>
<surname>Perna</surname> <given-names>N. T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Mauve: multiple alignment of conserved genomic sequence with rearrangements</article-title>. <source>Genome Res.</source> <volume>14</volume>, <fpage>1394</fpage>&#x2013;<lpage>1403</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gr.2289704</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Datta</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kontomichalou</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1965</year>). <article-title>Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae</article-title>. <source>Nature</source> <volume>208</volume>, <fpage>239</fpage>&#x2013;<lpage>241</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/208239a0</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Origins and evolution of antibiotic resistance</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>74</volume>, <fpage>417</fpage>&#x2013;<lpage>433</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MMBR.00016-10</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimitriu</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Evolution of horizontal transmission in antimicrobial resistance plasmids</article-title>. <source>Microbiol. (Reading)</source> <volume>168</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.001214</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Effelsberg</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kobusch</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Linnemann</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hofmann</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Schollenbruch</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Mellmann</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Prevalence and zoonotic transmission of colistin-resistant and carbapenemase-producing Enterobacterales on German pig farms</article-title>. <source>One Health</source> <volume>13</volume>, <elocation-id>100354</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.onehlt.2021.100354</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>EUCAST</collab>
</person-group> (<year>2023</year>) <source>Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1</source>. Available online at: <uri xlink:href="http://www.eucast.org">http://www.eucast.org</uri>.</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldgarden</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Brover</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Haft</surname> <given-names>D. H.</given-names>
</name>
<name>
<surname>Prasad</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Slotta</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Tolstoy</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Validating the AMRFinder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates</article-title>. <source>Antimicrobial. Agents Chemother.</source> <volume>63</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aac.00483-19</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finci</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Albertini</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Merker</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Andres</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bablishvili</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Barilar</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Investigating resistance in clinical <italic>Mycobacterium tuberculosis complex</italic> isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study</article-title>. <source>Lancet Microbe</source> <volume>3</volume>, <fpage>e672</fpage>&#x2013;<lpage>e682</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2666-5247(22)00116-1</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frost</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Leplae</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Summers</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Toussaint</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Mobile genetic elements: the agents of open source evolution</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>3</volume>, <fpage>722</fpage>&#x2013;<lpage>732</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro1235</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garza-Ramos</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Davila</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Alpuche-Aranda</surname> <given-names>C.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Collada</surname> <given-names>V. R.</given-names>
</name>
<name>
<surname>Alcantar-Curiel</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>The blaSHV-5 gene is encoded in a compound transposon duplicated in tandem in <italic>Enterobacter cloacae</italic>
</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>15</volume>, <fpage>878</fpage>&#x2013;<lpage>880</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02790.x</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girlich</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bonnin</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Proust</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Naas</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dortet</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Undetectable production of the VIM-1 carbapenemase in an <italic>atlantibacter hermannii</italic> clinical isolate</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.741972</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Quan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Emergence of ceftazidime/avibactam and tigecycline resistance in carbapenem-resistant <italic>klebsiella pneumoniae</italic> due to in-host microevolution</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.757470</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harmer</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>R. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An analysis of the IS6/IS26 family of insertion sequences: IS it a single family</article-title>? <source>Microbial. Genomics</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mgen.0.000291</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harmer</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>R. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>IS26 cannot move alone</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>76</volume>, <fpage>1428</fpage>&#x2013;<lpage>1432</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkab055</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hickman</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Varani</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Siguier</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dekker</surname> <given-names>J. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Insertion sequence IS26 reorganizes plasmids in clinically isolated multidrug-resistant bacteria by replicative transposition</article-title>. <source>mBio</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00762-15</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huemer</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mairpady Shambat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Brugger</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Zinkernagel</surname> <given-names>A. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antibiotic resistance and persistence-Implications for human health and treatment perspectives</article-title>. <source>EMBO Rep.</source> <volume>21</volume>, <elocation-id>e51034</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embr.202051034</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Innan</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kondrashov</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The evolution of gene duplications: classifying and distinguishing between models</article-title>. <source>Nat. Rev. Genet.</source> <volume>11</volume>, <fpage>97</fpage>&#x2013;<lpage>108</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrg2689</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname> <given-names>M. H. K.</given-names>
</name>
<name>
<surname>Bortolaia</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Tansirichaiya</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Aarestrup</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Petersen</surname> <given-names>T. N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Detection of mobile genetic elements associated with antibiotic resistance in <italic>Salmonella enterica</italic> using a newly developed web tool: MobileElementFinder</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>76</volume>, <fpage>101</fpage>&#x2013;<lpage>109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkaa390</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xfc;nemann</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sedlazeck</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Prior</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Albersmeier</surname> <given-names>A.</given-names>
</name>
<name>
<surname>John</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Kalinowski</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Updating benchtop sequencing performance comparison</article-title>. <source>Nat. Biotechnol.</source> <volume>31</volume>, <fpage>294</fpage>&#x2013;<lpage>296</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nbt.2522</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juraschek</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Borowiak</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tausch</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Malorny</surname> <given-names>B.</given-names>
</name>
<name>
<surname>K&#xe4;sbohrer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Otani</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Outcome of different sequencing and assembly approaches on the detection of plasmids and localization of antimicrobial resistance genes in commensal <italic>escherichia coli</italic>
</article-title>. <source>Microorganisms</source> <volume>9</volume>, <fpage>598</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms9030598</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>D.-W.</given-names>
</name>
<name>
<surname>Cha</surname> <given-names>C.-J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmission</article-title>. <source>Exp. Mol. Med.</source> <volume>53</volume>, <fpage>301</fpage>&#x2013;<lpage>309</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-021-00569-z</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kizny Gordon</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Mathers</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Cheong</surname> <given-names>E. Y. L.</given-names>
</name>
<name>
<surname>Gottlieb</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kotay</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>A. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections&#x2014;A systematic review of the literature</article-title>. <source>Clin. Infect. Dis.</source> <volume>64</volume>, <fpage>1435</fpage>&#x2013;<lpage>1444</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cid/cix132</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liakopoulos</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mevius</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ceccarelli</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>A review of SHV extended-spectrum &#x3b2;-lactamases: neglected yet ubiquitous</article-title>. <source>Front. Microbiol.</source> <volume>7</volume>, <elocation-id>1374</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2016.01374</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loftie-Eaton</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Bashford</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Quinn</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Millstein</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hunter</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Compensatory mutations improve general permissiveness to antibiotic resistance plasmids</article-title>. <source>Nat. Ecol. Evol.</source> <volume>1</volume>, <fpage>1354</fpage>&#x2013;<lpage>1363</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41559-017-0243-2</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meier-Kolthoff</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>G&#xf6;ker</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy</article-title>. <source>Nat. Commun.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-10210-3</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>C. J. L.</given-names>
</name>
<name>
<surname>Ikuta</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Sharara</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Swetschinski</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Robles Aguilar</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Gray</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet</source> <volume>399</volume>, <fpage>629</fpage>&#x2013;<lpage>655</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hemarajata</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rubio-Aparicio</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Tsivkovski</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Resistance to ceftazidime-avibactam is due to transposition of KPC in a porin-deficient strain of <italic>klebsiella pneumoniae</italic> with increased efflux activity</article-title>. <source>Antimicrobial. Agents Chemother.</source> <volume>61</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.00989-17</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ondov</surname> <given-names>B. D.</given-names>
</name>
<name>
<surname>Treangen</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Melsted</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mallonee</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Bergman</surname> <given-names>N. H.</given-names>
</name>
<name>
<surname>Koren</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Mash: fast genome and metagenome distance estimation using MinHash</article-title>. <source>Genome Biol.</source> <volume>17</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13059-016-0997-x</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Neill</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antimicrobial resistance: tackling a crisis for the health and wealth of nations 2014</article-title>. <source>Rev. Antimicrobial. Resist</source>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Partridge</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Kwong</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Firth</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Jensen</surname> <given-names>S. O.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mobile genetic elements associated with antimicrobial resistance</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>31</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00088-17</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Nash</surname> <given-names>J. H. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>MOB-suite: software tools for clustering, reconstruction and typing of plasmids from draft assemblies</article-title>. <source>Microbial. Genomics</source> <volume>4</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mgen.0.000206</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Varani</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Snesrud</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Alvarenga</surname> <given-names>D. O.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>TnCentral: a prokaryotic transposable element database and web portal for transposon analysis</article-title>. <source>mBio</source> <volume>12</volume>, <elocation-id>e0206021</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.02060-21</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>San Millan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>MacLean</surname> <given-names>R. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Fitness costs of plasmids: a limit to plasmid transmission</article-title>. <source>Microbiol. Spectr.</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/microbiolspec.mtbp-0016-2017</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuster</surname> <given-names>C. F.</given-names>
</name>
<name>
<surname>Weber</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Weig</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Werner</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Pfeifer</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>77</volume>, <fpage>381</fpage>&#x2013;<lpage>390</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkab407</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shropshire</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Konovalova</surname> <given-names>A.</given-names>
</name>
<name>
<surname>McDaneld</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gohel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Strope</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sahasrabhojane</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Systematic analysis of mobile genetic elements mediating &#x3b2;-lactamase gene amplification in noncarbapenemase-producing carbapenem-resistant enterobacterales bloodstream infections</article-title>. <source>mSystems</source> <volume>7</volume>, <elocation-id>e0047622</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/msystems.00476-22</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siguier</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Perochon</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lestrade</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Mahillon</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>ISfinder: the reference centre for bacterial insertion sequences</article-title>. <source>Nucleic Acids Res.</source> <volume>34</volume>, <fpage>D32</fpage>&#x2013;<lpage>D36</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkj014</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tacconelli</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Carrara</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Savoldi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Harbarth</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mendelson</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Monnet</surname> <given-names>D. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title>. <source>Lancet Infect. Dis.</source> <volume>18</volume>, <fpage>318</fpage>&#x2013;<lpage>327</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1473-3099(17)30753-3</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamamura-Andoh</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Niwa</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kinoshita</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Uchida-Fujii</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Arai</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Watanabe-Yanai</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Duplication of blaCTX-M-1 and a class 1 integron on the chromosome enhances antimicrobial resistance in <italic>Escherichia coli</italic> isolated from racehorses in Japan</article-title>. <source>J. Global Antimicrobial. Resist.</source> <volume>27</volume>, <fpage>225</fpage>&#x2013;<lpage>227</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jgar.2021.10.004</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanizawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Fujisawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>DFAST: a flexible prokaryotic genome annotation pipeline for faster genome publication</article-title>. <source>Bioinformatics</source> <volume>34</volume>, <fpage>1037</fpage>&#x2013;<lpage>1039</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btx713</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tansirichaiya</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>A. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The transposon registry</article-title>. <source>Mobile DNA</source> <volume>10</volume>, <fpage>40</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13100-019-0182-3</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>K. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Mechanisms of, and barriers to, horizontal gene transfer between bacteria</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>3</volume>, <fpage>711</fpage>&#x2013;<lpage>721</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro1234</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Almsick</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Schuler</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Mellmann</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Schwierzeck</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The Use of Long-Read Sequencing Technologies in Infection Control: Horizontal Transfer of a blaCTX-M-27 Containing lncFII Plasmid in a Patient Screening Sample</article-title>. <source>Microorganisms</source> <volume>10</volume>, <fpage>491</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms10030491</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>He</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Siguier</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Ross</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The IS6 family, a clinically important group of insertion sequences including IS26</article-title>. <source>Mobile DNA</source> <volume>12</volume>, <elocation-id>11</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13100-021-00239-x</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ventola</surname> <given-names>C. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The antibiotic resistance crisis: part 1: causes and threats</article-title>. <source>P T</source> <volume>40</volume>, <fpage>277</fpage>&#x2013;<lpage>283</lpage>.</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vosseberg</surname> <given-names>J.</given-names>
</name>
<name>
<surname>van Hooff</surname> <given-names>J. J. E.</given-names>
</name>
<name>
<surname>Marcet-Houben</surname> <given-names>M.</given-names>
</name>
<name>
<surname>van Vlimmeren</surname> <given-names>A.</given-names>
</name>
<name>
<surname>van Wijk</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Gabald&#xf3;n</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Timing the origin of eukaryotic cellular complexity with ancient duplications</article-title>. <source>Nat. Ecol. Evol.</source> <volume>5</volume>, <fpage>92</fpage>&#x2013;<lpage>100</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41559-020-01320-z</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vrancianu</surname> <given-names>C. O.</given-names>
</name>
<name>
<surname>Popa</surname> <given-names>L. I.</given-names>
</name>
<name>
<surname>Bleotu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chifiriuc</surname> <given-names>M. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Targeting plasmids to limit acquisition and transmission of antimicrobial resistance</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2020.00761</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>